The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer
Human Cell · 2024
DOI: 10.1007/s13577-024-01053-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Cell, 2024. Verfasst von Marta Zarzycka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland. marta.zarzycka@uj.edu.pl. Hauptthemen laut MEDLINE: Intercellular Adhesion Molecule-1, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Narodowe Centrum Nauki, Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum.
Abstract (Originalsprache)
Bladder cancer is one of the most prevalent cancers worldwide. Moreover, if not optimally treated, bladder cancer is a significant burden on healthcare systems due to multiple recurrences which often require more aggressive therapies. Therefore, targeted anti-cancer therapies, developed based on an in-depth understanding of specific proteins and molecular mechanisms, are promising in cancer treatment. Here, for the first time, we presented the new approaches indicating that intracellular adhesion molecule-1 (ICAM-1) may play a potential role in enhancing therapeutic effectiveness for bladder cancer. In the present study, we presented that ICAM-1 expression as well as its regulation in bladder cancer is strongly correlated with the high expression of N-cadherin. Importantly, the presence of N-cadherin and its regulator-TWIST-1 was abolished when ICAM-1 was silenced. We identified also that ICAM-1 is capable of regulating cellular migration, proliferation, and EMT progression in bladder cancer cells via the N-cadherin/SRC/AKT/GSK-3β/β-catenin signaling axis. Therefore, we propose ICAM-1 as a novel metastatic marker for EMT progression, which may also be used as a therapeutic target in bladder cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland. marta.zarzycka@uj.edu.pl.
- Department of Animal Anatomy and Preclinical Sciences, University Centre of Veterinary Medicine JU-UA, University of Agriculture in Kraków, Mickiewicza 24/28, 30-059, Kraków, Poland.
- Chair of Medical Biochemistry, Jagiellonian University Medical College, Kopernika 7, 31-034, Kraków, Poland.
Förderung
- Narodowe Centrum Nauki
- Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum
Zitieren
APA
Zarzycka, M., Kotula-Balak, M., & Gil, D. (2024). The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer. Human Cell. https://doi.org/10.1007/s13577-024-01053-2
Vancouver
Zarzycka M, Kotula-Balak M, Gil D. The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer. Human Cell. 2024. doi:10.1007/s13577-024-01053-2
BibTeX
@article{Zarzycka2024,
author = {Zarzycka, Marta and Kotula-Balak, Małgorzata and Gil, Dorota},
title = {The mechanism of the contribution of ICAM-1 to epithelial–mesenchymal transition (EMT) in bladder cancer},
journal = {Human Cell},
year = {2024},
doi = {10.1007/s13577-024-01053-2}
}
EUVIMED